JLS Pharma
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
09-07
abbreviated format · 22 days before the deadline
04-02
Gazette deed
Registered office moved from Louveigne to MeuxNew seat: Rue des Closières 21 à 5081 Meux · Previous seat: Rue de la China 29, 4141 LOUVEIGNE · Appointment: Christophe Scheiff (director)3 points ▸
Gazette deed
Registered office moved from Louveigne to Meux
New seat: Rue des Closières 21 à 5081 Meux · Previous seat: Rue de la China 29, 4141 LOUVEIGNE · Appointment: Christophe Scheiff (director)3 points ▸
- Director appointment, Christophe Scheiff (director)
- Registered-office move, Rue des Closières 21 à 5081 Meux
- General meeting, 30.09.25
2025
31-12
Financial
Highest result from 2022 to 2025net €71,664 ▲913%
The operating result of €95,618 and the net result of €71,664 are both a record.
06-10
full format · 67 days late
2024
31-12
Financial
Weakest financial yearnet €7,075 ▼52.4%
The net result drops to €7,075, the lowest from 2022 to 2025. It recovers the following year.
11-07
full format · 20 days before the deadline
2023
06-07
full format · 25 days before the deadline
2022
13-10
Gazette deed
Capital & sharesShare cancellation · Amendment of the articles · Capital5 points ▸
Gazette deed
Capital & shares
Share cancellation · Amendment of the articles · Capital5 points ▸
- General meeting, 11-10-2022
- Share cancellation, 4, “suppression pure et simple” (deed in French)
- Other provision, “sole shareholder and no justification” (deed in French)
- Amendment of the articles, 5
- Capital
2021
27-07
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank